A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

NCT00743769 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study never initiated due to contract manufacturing issues

Conditions

Myocardial Infarction
Myocardial Ischemia

Interventions

DRUG: thymosin beta 4
OTHER: Placebo

Sponsor

RegeneRx Biopharmaceuticals, Inc.